LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced on Thursday that it has launched a strategic evaluation to potentially integrate installment-based healthcare payment capabilities through Cashea, one of Venezuela's leading buy-now-pay-later financial technology platforms. The initiative aims to assess how to reduce upfront financial barriers for patients seeking private healthcare services, including consultations, diagnostics, wellness programs, and other eligible offerings within the LataMed AI ecosystem.
The company believes that improving payment accessibility could drive greater patient engagement, increase healthcare utilization, and strengthen platform adoption. By addressing affordability challenges, LataMed AI expects to enhance its position as a technology-enabled healthcare marketplace serving patients, providers, and healthcare partners across Latin America. The proposed integration, if completed, would support LataMed AI's broader strategy of combining artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment accessibility to create a more scalable healthcare marketplace.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: "We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while simultaneously expanding the reach and utility of our healthcare ecosystem. We believe initiatives such as this have the potential to strengthen patient acquisition, improve engagement, and support long-term platform growth."
The company has not yet entered into a definitive commercial agreement, and any integration remains subject to further commercial discussions, technical implementation requirements, regulatory review, and customary business conditions. LataMed AI intends to provide updates as material developments occur.
This move comes as LataMed AI continues to focus on emerging markets, with an initial regional focus on Latin America. The company's strategy centers on developing technology platforms to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, and data-driven healthcare operations. For more information, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at https://www.sec.gov.
Forward-looking statements in this release are based on current expectations and are subject to risks and uncertainties, including the company's ability to implement its business plan, secure financing, obtain regulatory approvals, and successfully negotiate payment integration arrangements. The company undertakes no obligation to update these statements.
